NCT06861244 2026-04-13
PNOC031
University of California, San Francisco
Phase 2 Recruiting
Clinical Trials
3 trialsNCT05583149 2026-01-29
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT07012447 2025-06-10
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
The First Affiliated Hospital of Soochow University
Phase 2 Recruiting